Assertio Holdings (ASRT) Net Margin Growth (3y) (2022 - 2026)

Assertio Holdings (ASRT) Net Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3,662.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -98.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,235.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 11,401.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4,252.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -404.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -15,806.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -987.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,232.00
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn -18,163.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,163.00
Dec 31, 2025 -26,377.00
Sep 30, 2025 1,094.00
Jun 30, 2025 -7,826.00
Mar 31, 2025 -7,576.00
Dec 31, 2024 -4,668.00
Sep 30, 2024 -2,467.00
Jun 30, 2024 4,420.00
Mar 31, 2024 -3,073.00
Dec 31, 2023 -9,329.00
Sep 30, 2023 -75,420.00
Jun 30, 2023 18,800.00
Mar 31, 2023 -20,532.00
Dec 31, 2022 50,117.00
Sep 30, 2022 616.00
Jun 30, 2022 4,608.00